Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Irene Viéitez"'
Autor:
Carlos Fernández-Pereira, Maria Aránzazu Penedo, Adrián Alonso-Núñez, Tania Rivera-Baltanás, Irene Viéitez, José María Prieto-González, María Isabel Vilariño-Vilariño, José Manuel Olivares, Saida Ortolano, Roberto Carlos Agís-Balboa
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
Introduction: Bipolar disorder (BD) is a recurrent and disabling psychiatric disorder related to low-grade peripheral inflammation and altered levels of the members of the insulin-like growth factor (IGF) family. The aim of this study was to evaluate
Externí odkaz:
https://doaj.org/article/8ecb2509160e4af8bdbdc08d9f2d8570
Autor:
Marketa Svobodova, Vasso Skouridou, Miriam Jauset-Rubio, Irene Viéitez, Alberto Fernández-Villar, Jorge Julio Cabrera Alvargonzalez, Eva Poveda, Clara Benavent Bofill, Teresa Sans, Abdulaziz Bashammakh, Abdulrahman O. Alyoubi, Ciara K. O’Sullivan
Publikováno v:
ACS Omega, Vol 6, Iss 51, Pp 35657-35666 (2021)
Externí odkaz:
https://doaj.org/article/b95067ca375c42d28d01d437f2a77a1b
Autor:
Maria Grazia Biferi, Mathilde Cohen-Tannoudji, Andrea García-Silva, Olga Souto-Rodríguez, Irene Viéitez-González, Beatriz San-Millán-Tejado, Andrea Fernández-Carrera, Tania Pérez-Márquez, Susana Teijeira-Bautista, Soraya Barrera, Vanesa Domínguez, Thibaut Marais, África González-Fernández, Martine Barkats, Saida Ortolano
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 1-17 (2021)
Fabry disease is a rare X-linked disorder affecting α-galactosidase A, a rate-limiting enzyme in lysosomal catabolism of glycosphingolipids. Current treatments present important limitations, such as low half-life and limited distribution, which gene
Externí odkaz:
https://doaj.org/article/b2d13278a02c48deb45d598f9f6bd188
Autor:
Hortensia Álvarez, Ezequiel Ruiz-Mateos, Pedro Miguel Juiz-González, Joana Vitallé, Irene Viéitez, María del Carmen Vázquez-Friol, Isabel Torres-Beceiro, Alberto Pérez-Gómez, Pilar Gallego-García, Nuria Estévez-Gómez, Loretta De Chiara, Eva Poveda, David Posada, Josep M. Llibre
Publikováno v:
Microorganisms, Vol 10, Iss 1, p 143 (2022)
Intra-host evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported in cases with persistent coronavirus disease 2019 (COVID-19). In this study, we describe a severely immunosuppressed individual with HIV-1/SARS-CoV
Externí odkaz:
https://doaj.org/article/c25d134b4c77454eb84f78708944c8ec
Autor:
Hasier, Eraña, Beatriz, San Millán, Carlos M, Díaz-Domínguez, Jorge M, Charco, Rosa, Rodríguez, Irene, Viéitez, Arrate, Pereda, Rosa, Yañez, Mariví, Geijo, Carmen, Navarro, Guiomar, Perez de Nanclares, Susana, Teijeira, Joaquín, Castilla
Publikováno v:
Journal of neurology. 269(8)
Gerstmann-Sträussler-Scheinker disease (GSS) is a rare neurodegenerative illness that belongs to the group of hereditary or familial Transmissible Spongiform Encephalopathies (TSE). Due to the presence of different pathogenic alterations in the prio
Autor:
Alexandre, Pérez-González, Alejandro, Araújo-Ameijeiras, Alberto, Fernández-Villar, Manuel, Crespo, Eva, Poveda, Irene, Viéitez
Publikováno v:
Scientific reports. 12(1)
Survivors to COVID-19 have described long-term symptoms after acute disease. These signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of this study is to describe persisting symptoms 6 months after COVID-19 diagnosis
Autor:
Martine Barkats, Irene Viéitez-González, África González-Fernández, Mathilde Cohen-Tannoudji, Andrea Fernandez-Carrera, Beatriz San-Millán-Tejado, Maria Grazia Biferi, Vanesa Domínguez, Saida Ortolano, Susana Teijeira-Bautista, Olga Souto-Rodriguez, Tania Pérez-Márquez, Thibaut Marais, Soraya Barrera, Andrea Garcia-Silva
Publikováno v:
Investigo. Repositorio Institucional de la Universidade de Vigo
Universidade de Vigo (UVigo)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 1-17 (2021)
Universidade de Vigo (UVigo)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 1-17 (2021)
Fabry disease is a rare X-linked disorder affecting α-galactosidase A, a rate-limiting enzyme in lysosomal catabolism of glycosphingolipids. Current treatments present important limitations, such as low half-life and limited distribution, which gene
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2885db2614f355e811d45393c2dc42a5
https://linkinghub.elsevier.com/retrieve/pii/S2329050120302205
https://linkinghub.elsevier.com/retrieve/pii/S2329050120302205
Publikováno v:
Human genetics. 127(1)
Autor:
Irene, Viéitez, Susana, Teijeira, Saida, Otolano, Patricia, Parente, Beatriz, San Millán, Carmen, Navarro
Publikováno v:
Human genetics. 125(3)
Publikováno v:
Human genetics. 124(3)